YM BioSciences (YMI) Posts Q1 Loss of $0.01, Sales Fall Short
Tweet
Share
E-mailGet Alerts YMI Hot Sheet
Join SI Premium – FREE
YM BioSciences (NYSE: YMI) reported Q1 EPS of ($0.01), $0.07 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $250.7 thousand versus the consensus estimate of $300 thousand.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna Group plc (KLAR) Tops Q2 EPS by 6c, Beats on Revenue; Offers FY26 Revenue Guidance
- Home Depot (HD) Tops Q2 EPS by 19c, reaffirms guidance
- VNET Group (VNET) Misses Q2 EPS by 164c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
